Prime Medicine stock hugs flat line following upsized $175M IPO (Pending:PRME)
seekingalpha.com
finance
2022-10-20 16:57:37

2d illustrations and photos/iStock via Getty Images Prime Medicine (PRME) shares hugged the flat line following the gene therapy developer's upsized $175M initial public offering on Thursday. Shares of Prime opened at $18.97 after being priced at $17 per share, hitting a high of $19 soon after opening. The stock recently changed hands at $16.95 at approximately 1:00 p.m. ET. Prime offered 10.3M shares priced at $17 apiece. Underwriters were granted a 30-day option to buy up to 1.5M additional shares.
